Chuck Royce's TECH Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 660.0K shares of Bio-Techne Corporation (TECH) worth $36.72 M, representing 0.37% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 44 quarters.
Based on 13F filings since 2013, Chuck Royce has maintained a long-term strategic position in TECH, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2015, adding 1.2M shares. Largest reduction occurred in Q1 2015, reducing 841.8K shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Bio-Techne Corporation (TECH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bio-Techne Corporation (TECH) Trades by Chuck Royce
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2014 | +2.45 M | New Buy | 2.45 M | $23.10 |
| Q1 2015 | -841,760 | Reduce 34.40% | 1.61 M | $25.07 |
| Q2 2015 | +416,296 | Add 25.93% | 2.02 M | $24.62 |
| Q3 2015 | +1.25 M | Add 61.59% | 3.27 M | $23.11 |
| Q4 2015 | +367,160 | Add 11.24% | 3.63 M | $22.50 |
| Q1 2016 | -295,240 | Reduce 8.12% | 3.34 M | $23.63 |
| Q2 2016 | -274,000 | Reduce 8.21% | 3.07 M | $28.19 |
| Q3 2016 | -99,600 | Reduce 3.25% | 2.97 M | $27.38 |
| Q4 2016 | +135,600 | Add 4.57% | 3.1 M | $25.71 |
| Q1 2017 | +118,400 | Add 3.82% | 3.22 M | $25.41 |
| Q2 2017 | -298,000 | Reduce 9.26% | 2.92 M | $29.37 |
| Q3 2017 | -285,400 | Reduce 9.77% | 2.64 M | $30.22 |
| Q4 2017 | -145,132 | Reduce 5.51% | 2.49 M | $32.39 |
| Q1 2018 | -209,484 | Reduce 8.41% | 2.28 M | $37.76 |
| Q2 2018 | -319,200 | Reduce 13.99% | 1.96 M | $36.99 |
| Q3 2018 | -608,812 | Reduce 31.03% | 1.35 M | $51.03 |
| Q4 2018 | -158,052 | Reduce 11.68% | 1.2 M | $36.18 |
| Q1 2019 | -133,600 | Reduce 11.18% | 1.06 M | $49.64 |
| Q2 2019 | -72,140 | Reduce 6.79% | 989,616 | $52.12 |
| Q3 2019 | +51,364 | Add 5.19% | 1.04 M | $48.92 |
| Q4 2019 | -141,572 | Reduce 13.60% | 899,408 | $54.88 |
| Q1 2020 | -7,472 | Reduce 0.83% | 891,936 | $47.40 |
| Q2 2020 | -49,600 | Reduce 5.56% | 842,336 | $66.02 |
| Q3 2020 | +3,532 | Add 0.42% | 845,868 | $61.93 |
| Q4 2020 | -83,524 | Reduce 9.87% | 762,344 | $79.39 |
| Q1 2021 | -41,516 | Reduce 5.45% | 720,828 | $95.48 |
| Q2 2021 | -211,796 | Reduce 29.38% | 509,032 | $112.56 |
| Q3 2021 | -193,396 | Reduce 37.99% | 315,636 | $121.14 |
| Q4 2021 | -9,864 | Reduce 3.13% | 305,772 | $129.33 |
| Q1 2022 | +11,712 | Add 3.83% | 317,484 | $108.26 |
| Q2 2022 | +65,956 | Add 20.77% | 383,440 | $86.66 |
| Q3 2022 | +22,552 | Add 5.88% | 405,992 | $71.00 |
| Q4 2022 | +46,122 | Add 11.36% | 452,114 | $82.88 |
| Q1 2023 | +243,089 | Add 53.77% | 695,203 | $74.19 |
| Q2 2023 | -149,564 | Reduce 21.51% | 545,639 | $81.63 |
| Q3 2023 | +128,646 | Add 23.58% | 674,285 | $68.07 |
| Q4 2023 | +9,185 | Add 1.36% | 683,470 | $77.16 |
| Q1 2024 | +113,094 | Add 16.55% | 796,564 | $70.39 |
| Q2 2024 | +31,538 | Add 3.96% | 828,102 | $71.65 |
| Q3 2024 | +17,296 | Add 2.09% | 845,398 | $79.93 |
| Q4 2024 | +15,353 | Add 1.82% | 860,751 | $72.03 |
| Q1 2025 | +9,434 | Add 1.10% | 870,185 | $58.63 |
| Q2 2025 | +702 | Add 0.08% | 870,887 | $51.45 |
| Q3 2025 | -210,853 | Reduce 24.21% | 660,034 | $55.63 |
Chuck Royce's Bio-Techne Corporation Investment FAQs
Chuck Royce first purchased Bio-Techne Corporation (TECH) in Q4 2014, acquiring 2,447,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Bio-Techne Corporation (TECH) for 44 quarters since Q4 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce's largest addition to Bio-Techne Corporation (TECH) was in Q4 2014, adding 2,447,300 shares worth $56.53 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Chuck Royce's firm, Royce & Associates Lp, owns 660,034 shares of Bio-Techne Corporation (TECH), valued at approximately $36.72 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Bio-Techne Corporation (TECH) represents approximately 0.37% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce's peak holding in Bio-Techne Corporation (TECH) was 3,634,276 shares, as reported at the end of Q4 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.